Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clinical Evaluation of Narrow Band Imaging Colonoscope
This study has been completed.
Sponsored by: VA Palo Alto Health Care System
Information provided by: VA Palo Alto Health Care System
ClinicalTrials.gov Identifier: NCT00628147
  Purpose

The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.


Condition Intervention Phase
Colonic Neoplasms
Device: Narrow band imaging colonoscope (CF-H180AL, CF-Q180AL, Evis Exera II CV-180)
Phase IV

MedlinePlus related topics: Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Randomized, Single Blind (Subject), Parallel Assignment, Efficacy Study
Official Title: Tandem Colonoscopy Study of Narrow Band Imaging Versus White Light Examination to Compare Neoplasia Miss Rates

Further study details as provided by VA Palo Alto Health Care System:

Primary Outcome Measures:
  • neoplasm miss rate [ Time Frame: same day ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • neoplasm detection rates [ Time Frame: same day ] [ Designated as safety issue: No ]
  • completion of examinations [ Time Frame: same day ] [ Designated as safety issue: No ]
  • procedure complications [ Time Frame: procedure and post-procedure complications within 30 days after colonoscopy ] [ Designated as safety issue: Yes ]

Enrollment: 284
Study Start Date: January 2006
Study Completion Date: March 2007
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
narrow band imaging colonoscope
Device: Narrow band imaging colonoscope (CF-H180AL, CF-Q180AL, Evis Exera II CV-180)
Adult colonoscopes with narrow band imaging capabilities (XCF-H160AY2L and XCF-Q160W6L, Olympus Medical Systems Corporation, Hachioji, Japan). There is an automatic switch on the handle of the endoscope that allows the physician to instantly switch between narrow band imaging and standard full spectrum white light modes.

Detailed Description:

This is a clinical study to evaluate whether the use of a new type of colonoscope may improve the detection of colon polyps. Though colonoscopy is currently the best test for colon cancer screening, it remains imperfect. Research has found that about 25% of polyps may actually be missed during colonoscopy using standard full spectrum white light imaging. Advances in colonoscopic technology hold the potential to decrease the miss rate of colorectal neoplasms. A new colonoscope uses narrow band imaging, whereby the colon is illuminated using only a subset of the white light spectrum, 415nanometers (blue) and 540 nanometers (green) rather than the standard full spectrum white light (red, green and blue). Initial studies by other groups suggest that these narrow band images highlight small blood vessels of colon polyps. As such, we hypothesized that the use of NBI would improve the identification of neoplasms through the color differentiation of precancerous or cancerous polyp (appearing brown) from normal colon mucosal lining (appearing green), and potentially lead to a reduction in polyp miss rate. We aimed to study the polyp miss rate, and compare narrow band imaging to white light examination.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • referred for elective outpatient colonoscopy

Exclusion Criteria:

  • known inflammatory bowel disease
  • personal or family history of polyposis syndrome
  • referral for resection of a known lesion
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00628147

Locations
United States, California
VAPaloAltoHCS
Palo Alto, California, United States, 94304
Sponsors and Collaborators
VA Palo Alto Health Care System
Investigators
Principal Investigator: Roy Soetikno, MD, MS VA Palo Alto Health Care System
  More Information

Publications indexed to this study:
Responsible Party: VA Palo Alto Health Care System ( Roy Soetikno )
Study ID Numbers: SOE0011
Study First Received: February 25, 2008
Last Updated: March 3, 2008
ClinicalTrials.gov Identifier: NCT00628147  
Health Authority: United States: Federal Government;   United States: Institutional Review Board

Keywords provided by VA Palo Alto Health Care System:
colonic neoplasms
colonoscopy
narrow band imaging
diagnostic techniques

Study placed in the following topic categories:
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Colonic Neoplasms
Intestinal Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009